Verus Capital Partners »

Aquestive Therapeutics shares owned by Verus Capital Partners

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Verus Capital Partners from 13F filings

Historical chart of Verus Capital Partners investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Verus Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Verus Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $393k 61k 6.46
2025-09-30 $188k 34k 5.59

More positions owned by Verus Capital Partners

Apple (AAPL)
NVIDIA Corporation Call Option (NVDA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust State Street Spd (SPYG)
Ishares Tr Core S&p500 Etf (IVV)
Guggenheim Strategic Opportu Com Sbi (GOF)
Spdr Series Trust State Street Spd (SPYM)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Palantir Technologies Cl A (PLTR)

View all positions for Verus Capital Partners

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Perceptive Advisors
EcoR1 Capital
Samsara BioCapital
State Street Corporation
Geode Capital Management
Federated Investors
Sio Capital Management
Millennium Management
Susquehanna International
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc

View all funds holding Aquestive Therapeutics